Literature DB >> 22651942

Risk of dementia in an elderly population of Parkinson's disease patients: a 15-year population-based study.

Florian Perez1, Catherine Helmer, Alexandra Foubert-Samier, Sophie Auriacombe, Jean-François Dartigues, François Tison.   

Abstract

BACKGROUND: The incidence of dementia in Parkinson's disease (PD) is not fully known, and previous studies have provided a wide range of rates owing to variations in diagnostic criteria and methodologies used. We estimated the risk of dementia in newly diagnosed cases of PD in a population-based cohort of subjects aged >65 years.
METHODS: We performed repetitive systematic screening of PD diagnosis, cognitive performances, and clinical dementia during 15 years (at year 0, 3, 5, 8, 10, and 15) in 3726 elderly subjects living at home in southwestern France (PAQUID). Two sets of diagnostic criteria for dementia in PD were considered: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised criteria and Movement Disorders Society criteria.
RESULTS: Forty-four incident cases of PD occurred in the cohort; of these, 18 (41%) developed dementia during a mean follow-up of 6.8 ± 3.6 years. Incidence rate of dementia associated with PD was 74 per 1000 patient-years. The cumulative risk of dementia was approximately 25% and 50% after 5 and 10 years of follow-up, respectively. The relative risk for developing dementia in incident PD subjects compared with non-PD subjects was 2.47 (1.55-3.95). Equivalent estimations were obtained with Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised criteria or Movement Disorders Society criteria.
CONCLUSION: PD represents a high-risk stage for dementia in the general population.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22651942     DOI: 10.1016/j.jalz.2011.09.230

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  15 in total

Review 1.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 2.  Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-20       Impact factor: 3.850

Review 3.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

4.  Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus.

Authors:  Isabelle Bardou; Holly M Brothers; Roxanne M Kaercher; Sarah C Hopp; Gary L Wenk
Journal:  Neurobiol Aging       Date:  2013-04-30       Impact factor: 4.673

Review 5.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

6.  The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson's disease and controls.

Authors:  Carl Counsell; Cinzia Giuntoli; Qaisar Imran Khan; Jodi Maple-Grødem; Angus D Macleod
Journal:  J Neurol       Date:  2022-03-21       Impact factor: 6.682

7.  Cognitive impairments in Parkinson's disease: Evidence from an Iranian population.

Authors:  Farzad Ashrafi; Alireza Zali; Hossein Pakdaman; Karim Johari
Journal:  Iran J Neurol       Date:  2012

Review 8.  Psychiatric aspects of Parkinson's disease.

Authors:  Sandeep Grover; Mansi Somaiya; Santhosh Kumar; Ajit Avasthi
Journal:  J Neurosci Rural Pract       Date:  2015-01

Review 9.  MicroRNAs in age-related diseases.

Authors:  Stefanie Dimmeler; Pierluigi Nicotera
Journal:  EMBO Mol Med       Date:  2013-01-22       Impact factor: 12.137

Review 10.  Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.

Authors:  Jie Dong; Yanhua Cui; Song Li; Weidong Le
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.